1. Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. <em>Mol Aspects Med</em>. 2008;29(6): 361-368.
2. Medrano M, Carrillo-Cruz E, Montero I, Perez-Simon JA. Vitamin D: effect on haematopoiesis and immune system and clinical applications. <em>Int J Mol Sci</em>. 2018;19(9):2663.
3. Hall AC, Juckett MB. The role of vitamin D in hematologic disease and stem cell transplantation. <em>Nutrients</em>. 2013;5(6):2206-2221.
4. Ros-Soto J, Anthias C, Madrigal A, Snowden JA. Vitamin D: is it important in haematopoietic stem cell transplantation? A review. <em>Bone Marrow Transplant</em>. 2019;54(6):810-20.
5. Soto JR, Anthias C, Madrigal A, Snowden JA. Insights into the role of vitamin D as a biomarker in stem cell transplantation. <em>Front Immunol</em>. 2020;11:966.
6. Brown G, Choudhry MA, Durham J, Drayson MT, Michell RH. Monocytically differentiating HL60 cells proliferate rapidly before they mature. <em>Exp Cell Res</em>. 1999;253(2):511-518.
7. Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D, Hoang T. Impaired granulocytic differentiation in vitro in hematopoietic cells lacking retinoic acid receptors alpha1 and gamma. <em>Blood</em>. 1998;92(2):607-615.
8. O’Kelly J, Hisatake J, Hisatake Y, Bishop J, Norman A, Koeffler HP. Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. <em>J Clin Invest</em>. 2002;109(8):1091-1099.
9. Yu S, Zhao J, Cantorna MT. Invariant NKT cell defects in vitamin D receptor knockout mice prevents experimental lung inflammation. <em>J Immunol</em>. 2011;187(9):4907-4912.
10. Bajwa RP, Taylor K, Hoyt AR, et al. Effects of vitamin D levels on outcomes after allogeneic hematopoietic stem cell transplantation in children. <em>Biol Blood Marrow Transplantation</em>. 2019;25(3):S239-S240.
11. von Bahr L, Blennow O, Alm J, Björklund A, Malmberg KJ, Mougiakakos D, et al. Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation. <em>Bone Marrow Transplant</em>. 2015;50(9):1217-1223.
12. Kreutz M, Eissner G, Hahn J, Andreesen R, Drobnik W, Holler E. Variations in 1 alpha, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 serum levels during allogeneic bone marrow transplantation. <em>Bone Marrow Transplant</em>. 2004;33(8):871-873.
13. Caballero-Velázquez T, Montero I, Sánchez-Guijo F, et al. Immunomodulatory effect of vitamin D after allogeneic stem cell transplantation: results of a prospective multicenter clinical trial. Clinical Trial.<em>Clin Cancer Res</em>. 2016;22(23):5673-5681.
14. Huber BC, Grabmaier U, Brunner S. Impact of parathyroid hormone on bone marrow-derived stem cell mobilization and migration. <em>World J Stem Cells</em>. 2014;6(5):637-643.
15. Saraceni F, Shem-Tov N, Olivieri A, Nagler A. Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective. <em>Bone Marrow Transplant</em>. 2015;50(7):886-891.
16. de Kruijf EFM, Fibbe WE, van Pel M. Cytokine-induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche. <em>Ann N Y Acad Sci</em>. 2020;1466(1):24-38.
17. Bailén R, Pérez-Corral AM, Pascual C, Kwon M, Serrano D, Gayoso J, et al. Factors predicting peripheral blood progenitor cell mobilization in healthy donors in the era of related alternative donors: Experience from a single center. <em>J Clin Apher</em>. 2019;34(4):373-380.
18. Hopman RK, DiPersio JF. Advances in stem cell mobilization. <em>Blood Rev</em>. 2014;28(1):31-40.
19. Çelik S, Kaynar L, Güven ZT, et al. The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study.<em>Transfus Apher Sci</em>. 2023;62(6):103838.
20. Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, et al. Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. <em>Biol Blood Marrow Transplant</em>. 2011;17(8):1146-1153.
21. Mikirova NA, Jackson JA, Hunninghake R, et al. Nutraceutical augmentation of circulating endothelial progenitor cells and hematopoietic stem cells in human subjects.<em>J Transl Med</em>. 2010;8:34.
22. Grande A, Montanari M, Tagliafico E, Manfredini R, Zanocco Marani T, Siena M, et al. Physiological levels of 1alpha, 25 dihydroxyvitamin D3 induce the monocytic commitment of CD34+ hematopoietic progenitors. <em>J Leukoc Biol</em>. 2002;71(4):641-651.
23. Hansson ME, Norlin AC, Omazic B, et al. Vitamin D levels affect outcome in pediatric hematopoietic stem cell transplantation. <em>Biol Blood Marrow Transplant</em>. 2014;20(10):1537-1543.
24. Brunner S, Zaruba M-M, Huber B, David R, Vallaster M, Assmann G, et al. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow. <em>Exp Hematol</em>. 2008;36(9):1157-1166.
25. Brunner S, Theiss HD, Leiss M, Grabmaier U, Grabmeier J, Huber B, et al. Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. <em>Basic Res Cardiol</em>. 2013;108(6):388.
26. Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, et al. Phase I trial of parathyroid hormone to facilitate stem cell mobilization. <em>Biol Blood Marrow Transplant</em>. 2007;13(7):838-843.